AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITHAIDS - RELIABILITY OF RELATIVELY HIGH-DOSES OVER A RELATIVELY SHORT-PERIOD - REPLY
F. Delalla et al., AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITHAIDS - RELIABILITY OF RELATIVELY HIGH-DOSES OVER A RELATIVELY SHORT-PERIOD - REPLY, Clinical infectious diseases, 21(5), 1995, pp. 1353-1353